title: Reversal of cardiac and large artery structural abnormalities induced by long-term antihypertensive treatment with trandolapril.
abstract: In 15 patients with untreated mild to moderate essential hypertension and left ventricular hypertrophy, we assessed blood pressure, echocardiographic left ventricular mass index, brachial artery compliance (pulsed doppler flowmetry), and calculated forearm vascular resistance (strain gauge plethysmography) before, during (6 and 12 months) and after (1 month washout period) 1 year of satisfactory (blood pressure < or = 140/90 mm Hg) antihypertensive therapy with the angiotensin-converting enzyme inhibitor trandolapril (2.0 mg orally once daily). During the antihypertensive effective treatment, we observed a significant reduction of systolic and diastolic blood pressures, left ventricular mass index, and forearm vascular resistance at both 6 and 12 months. In addition, brachial artery compliance was significantly increased. After washout, systolic (156 +/- 3 mm Hg) and diastolic (102 +/- 1 mm Hg) blood pressures returned to levels comparable to baseline. However, left ventricular mass index (132 +/- 4; p < 0.01) and brachial artery compliance (1.53 +/- 0.01; p < 0.01) were still different from baseline. These results demonstrate that chronic antihypertensive treatment with trandolapril is associated with a stable regression of cardiac and vascular abnormalities, which is partially unrelated to the blood pressure lowering effect.
authors.affiliation: I Clinica Medica, University of Naples, Milan, Italy.
authors.forename: N
authors.initials: N
authors.lastname: De Luca
authors.forename: G
authors.initials: G
authors.lastname: Rosiello
authors.forename: F
authors.initials: F
authors.lastname: Lamenza
authors.forename: B
authors.initials: B
authors.lastname: Ricciardelli
authors.forename: R
authors.initials: R
authors.lastname: Marchegiano
authors.forename: M
authors.initials: M
authors.lastname: Volpe
authors.forename: C
authors.initials: C
authors.lastname: Marelli
authors.forename: B
authors.initials: B
authors.lastname: Trimarco
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D001158:Arteries / Q000187:drug effects* / Q000503:physiopathology; D001916:Brachial Artery / Q000503:physiopathology; D003187:Compliance; D005542:Forearm / Q000098:blood supply; D006321:Heart / Q000187:drug effects* / Q000503:physiopathology; D006439:Hemodynamics; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D007211:Indoles / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D007211:Indoles; C052035:trandolapril